AN2 Therapeutics, Inc.'s total assets for Q1 2026 were $87.49M, an increase of 41.23% from the previous quarter. ANTX total liabilities were $5.73M for the fiscal quarter, a -35.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.